$Pfizer (PFE.US)$
The stock has broken the 26.83 resistance. Next hit point will be 27.15.

$Pfizer (PFE.US)$
Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
The Health Ministry said on Jan 4 that HMPV – a respiratory tract infection caused by a virus in the Pneumoviridae family – is not a new disease.
Those with HMPV typically experience symptoms similar to those of a common cold, but in more severe cases the symptoms can progress to bronchitis or pneumonia.
Malaysia recorded 327 HMPV cases in 2024; Health Ministry urges public to remain vigilant | The Straits Times

US stock market rebounded strongly last Friday to clock its first gain since Christmas.
As we enter 2025 and put aside the Santa Rally’s absence, investors could be looking at another indicator which has correctly forecasted full year stock performance with a 70 to 80% accuracy since 1950.
Check out the video to find out more.
Stocks covered in the video (technical analysis) – SPY, Apple, Tesla, Google, Meta, Microsoft, Nvidia + Option trades 
$Netflix (NFLX.US)$ $Advanced Micro Devices (AMD.US)$ $Taiwan Semiconductor (TSM.US)$ $Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Adobe (ADBE.US)$ $Enphase Energy (ENPH.US)$ $KraneShares CSI China Internet ETF (KWEB.US)$ $Arm Holdings (ARM.US)$ $MARA Holdings (MARA.US)$ $Riot Platforms (RIOT.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Johnson & Johnson (JNJ.US)$ $JPMorgan (JPM.US)$ $Disney (DIS.US)$

A Quick Review of my Trading Activities in this week (30 Dec 2024 to 3 Jan 2025).
New Positions
$Uber Technologies (UBER.US)$ , $Global X Funds Mlp & Energy Infrastructure Etf (MLPX.US)$ , $Life360 (LIF.US)$
Increased Positions
$Energy Select Sector SPDR Fund (XLE.US)$ , $Occidental Petroleum (OXY.US)$ , $Johnson & Johnson (JNJ.US)$ , $Advanced Micro Devices (AMD.US)$
Decreased Positions
$Tesla (TSLA.US)$
Sold out Positions
$Hut 8 (HUT.US)$ (Lost 13.3%) , $Innodata (INOD.US)$ (Profit 5...

$Pfizer (PFE.US)$
Updates with response from Bristol-Myers Squibb in the fourth and fifth paragraphs.
Drugmakers including Pfizer (PFE), Bristol-Myers Squibb (BMY) and Sanofi (SNY) plan to raise US list prices on at least 250 branded medications, including COVID-19 treatments, cancer cell therapies and vaccines, at the start of 2025, Reuters reported Tuesday, citing data from the healthcare research firm 3 Axis Advisors.
Most of the price hikes are below 10% and are to list prices, which do not i...